MARKET

CME

CME

CME Group
NASDAQ

Real-time Quotes | Nasdaq Last Sale

184.03
+2.32
+1.28%
After Hours: 184.03 0 0.00% 17:21 12/04 EST
OPEN
182.34
PREV CLOSE
181.71
HIGH
185.11
LOW
181.72
VOLUME
1.32M
TURNOVER
--
52 WEEK HIGH
225.36
52 WEEK LOW
131.80
MARKET CAP
66.06B
P/E (TTM)
30.67
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
There's A Lot To Like About CME Group's (NASDAQ:CME) Upcoming US$0.85 Dividend
Simply Wall St. · 11h ago
CME Group Chief Financial Officer and Global Head of Financial and OTC Products to Present at Goldman Sachs 2020 U.S. Financial Services Conference
CME Group announced today that John Pietrowicz, Chief Financial Officer and Sean Tully, Global Head of Financial and OTC Products, will present virtually at the Goldman Sachs 2020 U.S. Financial Services Conference on Tuesday, December 8, 2020, at 9:20 a.m. (Eastern Time).
PR Newswire · 1d ago
CME Group's (CME) November ADV Rises at Three Product Lines
CME Group's (CME) average daily volume of 19.3 million contracts per day in November 2020 rises 6% year over year.
Zacks · 2d ago
CME Group's overall November ADV grew 6% Y/Y
For November 2020, CME Group (CME) reported average daily volume of 19.3M contracts while overall ADV grew 6% Y/Y.Interest Rate ADV of 8.8M contracts, equity index ADV of 5.4M contracts and
Seekingalpha · 3d ago
CME Group Reports November 2020 Monthly Market Statistics
CME Group, the world's leading and most diverse derivatives marketplace, today reported November 2020 market statistics, including average daily volume (ADV) of 19.3 million contracts during the month. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.
PR Newswire · 3d ago
Farmer sentiment pulls back post-election: regulation, trade, and taxes rated as top concerns
The Purdue University/CME Group Ag Economy Barometer dropped 16 points to a reading of 167 in November, down from its all-time high set just one month ago. The decrease in sentiment was led by farmers' more pessimistic view towards the future of the agricultural economy with the Index of Future Expectations falling 30 points to a reading of 156 in November. The on-going rally in commodity prices and CFAP-2 payments continued to support producers' view of current economic conditions as the Index of Current Conditions rose 9 points in November to 187, an all-time high for the index.
PR Newswire · 4d ago
As bitcoin rallies back to a record, here are some popular derivative plays
These funds and publicly traded stocks are a way for investors to gain exposure to the red-hot cryptocurrency.
CNBC.com · 4d ago
S&P Puts $44 Billion on Wise ‘Big Is Better’ Wager
(Bloomberg Opinion) -- If the world is going to end up with just a handful of gigantic global businesses serving its financial markets, the U.S. is clearly leading the race. The agreed combination of S&P Global Inc. and IHS Markit Ltd. stands to create a vast, international and diversified business — one that has strategic options to get even bigger through further acquisitions. It’s a transaction that has implications for the U.S. players in market infrastructure and for the capital markets more broadly.S&P, with a market value of $82 billion, has agreed to a deal valuing IHS debt-free at $44 billion. The terms see IHS shareholders receive stock worth around $97 per share, a 4.7% premium to the closing value on Friday. While S&P is the larger party, the pair are casting this as a merger, hence the modest uplift, which would be much larger in a conventional takeover of the U.S.-listed, London-based group.The strategic rationale and timing are easy to grasp. S&P is a well-known brand in indices. It gains enhanced data and analytics capabilities and broader distribution. IHS’s business may be able to grow faster with the benefit of S&P’s clout. Scale brings efficiencies: The duo is targeting $480 million of annual cost savings, with revenue synergies on top.IHS bought Markit in 2016 and may now be at the limits of realizing the full benefits of that deal. S&P and IHS’s market enterprise valuations are both 21 times profit expected next year on the Ebitda measure. That probably made negotiations easier.There are some worries for shareholders. One is whether regulators might stymie the tie-up. The other is the possibility a deal that makes sense on paper founders on the execution. An agile and robust IT system is critical to making a transaction like this deliver. The continuing involvement of IHS Chairman and Chief Executive Officer Lance Uggla appears critical. He’s staying on for a year as an advisor. Hopefully that will be long enough. For S&P, there’s the risk IHS gets a counterbid.The deal comes as London Stock Exchange Group Plc’s $27 billion takeover of data provider Refinitiv continues to work its way through the antitrust process. That marked a pivot to North America after the collapse of LSE’s planned merger with Deutsche Boerse AG. Continental Europe appears to have missed its chance to create a truly global, diversified market infrastructure powerhouse. Bloomberg LP, the parent of Bloomberg News, competes with IHS Markit, S&P Global and Refinitiv in providing financial analytics and information.This will not be the last word in consolidation. Assuming a smooth integration, the logical next step would be further diversification through M&A. Exchange provider CME Group Inc. already has a business partnership in indices with S&P. It looks a potential good fit. That in turn raises questions about how Intercontinental Exchange Inc. will respond to all this. Might it now also seek more scale, say by targeting a deal with a group such as MSCI Inc., notwithstanding that the index and analytics provider is valued more richly than ICE?Either way, the market data business is getting bigger and the U.S.’s global role is matching the size and depths of its markets.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Chris Hughes is a Bloomberg Opinion columnist covering deals. He previously worked for Reuters Breakingviews, as well as the Financial Times and the Independent newspaper.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Bloomberg · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CME. Analyze the recent business situations of CME Group through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CME stock price target is 172.89 with a high estimate of 197.00 and a low estimate of 135.00.
EPS
Institutional Holdings
Institutions: 1.43K
Institutional Holdings: 324.65M
% Owned: 90.43%
Shares Outstanding: 358.99M
TypeInstitutionsShares
Increased
349
17.17M
New
165
-62.54K
Decreased
410
17.52M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Financial & Commodity Market Operators & Service Providers
+0.77%
Investment Banking & Investment Services
+1.30%
Key Executives
Chairman/Chief Executive Officer/Director
Terrence Duffy
Vice Chairman/Director
Charles Carey
Chief Financial Officer
John Pietrowhicz
Corporate Executive
Sunil Cutinho
Chief Human Resource Officer/Senior Managing Director
Hilda Piell
Chief Accounting Officer
Jack Tobin
Chief Information Officer/Senior Managing Director
Kevin Kometer
General Counsel/Senior Managing Director/Secretary
Kathleen Cronin
Senior Managing Director/Chief Operating Officer
Julie Holzrichter
Senior Managing Director
Derek Sammann
Senior Managing Director
Sean Tully
Senior Managing Director
Kendal Vroman
Senior Managing Director
Julie Winkler
Lead Director/Independent Director
Daniel Glickman
Director
Michael Spencer
Independent Director
Timothy Bitsberger
Independent Director
Dennis Chookaszian
Independent Director
Elizabeth Cook
Independent Director
Ana Dutra
Independent Director
Martin Gepsman
Independent Director
Larry Gerdes
Independent Director
Yra Harris
Independent Director
Gedon Hertshten
Independent Director
William Hobert
Independent Director
Daniel Kaye
Independent Director
Phyllis Lockett
Independent Director
Deborah Lucas
Independent Director
Patrick Maloney
Independent Director
Ronald Pankau
Independent Director
Terry Savage
Independent Director
William Shepard
Independent Director
Howard Siegel
Independent Director
Dennis Suskind
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
11/05/2020
Dividend USD 0.85
12/09/2020
08/06/2020
Dividend USD 0.85
09/09/2020
05/05/2020
Dividend USD 0.85
06/09/2020
02/05/2020
Dividend USD 0.85
03/09/2020
12/11/2019
Dividend USD 0
12/26/2019
12/11/2019
Special Dividend USD 2.5
12/26/2019
11/06/2019
Dividend USD 0.75
12/09/2019
08/07/2019
Dividend USD 0.75
09/09/2019
05/07/2019
Dividend USD 0.75
06/07/2019
02/06/2019
Dividend USD 0.75
03/07/2019
12/05/2018
Dividend USD 0
12/27/2018
12/05/2018
Special Dividend USD 1.75
12/27/2018
11/08/2018
Dividend USD 0.7
12/07/2018
08/08/2018
Dividend USD 0.7
09/07/2018
05/09/2018
Dividend USD 0.7
06/07/2018
02/07/2018
Dividend USD 0.7
03/08/2018
12/06/2017
Dividend USD 0
12/27/2017
12/06/2017
Special Dividend USD 3.5
12/27/2017
11/08/2017
Dividend USD 0.66
12/07/2017
08/02/2017
Dividend USD 0.66
09/07/2017
05/23/2017
Dividend USD 0.66
06/07/2017
02/08/2017
Dividend USD 0.66
03/08/2017
12/07/2016
Dividend USD 0
12/23/2016
12/07/2016
Special Dividend USD 3.25
12/23/2016
11/09/2016
Dividend USD 0.6
12/07/2016
08/03/2016
Dividend USD 0.6
09/07/2016
05/17/2016
Dividend USD 0.6
06/08/2016
02/03/2016
Dividend USD 0.6
03/08/2016
12/09/2015
Dividend USD 2.9
12/23/2015
11/11/2015
Dividend USD 0.5
12/08/2015
08/05/2015
Dividend USD 0.5
09/08/2015
05/19/2015
Dividend USD 0.5
06/08/2015
02/04/2015
Dividend USD 0.5
03/06/2015
12/10/2014
Dividend USD 2
12/24/2014
11/05/2014
Dividend USD 0.47
12/08/2014
08/06/2014
Dividend USD 0.47
09/08/2014
05/20/2014
Dividend USD 0.47
06/06/2014
02/05/2014
Dividend USD 0.47
03/06/2014
12/11/2013
Dividend USD 2.6
12/24/2013
11/05/2013
Dividend USD 0.45
12/06/2013
08/07/2013
Dividend USD 0.45
09/06/2013
--
Dividend USD 0.45
06/06/2013
01/30/2013
Dividend USD 0.45
03/06/2013
12/05/2012
Dividend USD 1.3
12/13/2012
11/07/2012
Dividend USD 0.45
12/06/2012
08/08/2012
Dividend USD 0.45
09/06/2012
05/24/2012
Dividend USD 2.23
06/06/2012
02/02/2012
Dividend USD 5.23
03/07/2012
12/07/2011
Dividend USD 1.4
12/15/2011
08/03/2011
Dividend USD 1.4
09/07/2011
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CME
CME Group Inc., through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company's segment primarily consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX) exchanges. The Company provides electronic trading around the globe on its CME Globex platform. The Company also offers clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives through its clearinghouses CME Clearing and CME Clearing Europe. It also provides hosting, connectivity and customer support for electronic trading through its co-location services. The Company's CME Direct platform offers side-by-side trading of exchange-listed and privately negotiated markets.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of CME Group Inc stock information, including NASDAQ:CME real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CME stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CME stock methods without spending real money on the virtual paper trading platform.